An investor consortium of Nautic Partners, The Vistria Group and General Atlantic have bought PANTHERx Rare from Centene Corporation.
The partnership will accelerate PANTHERx Rare’s growth as a pharmacy care delivery model for patients with rare diseases.
General Atlantic is a growth equity firm. Nautic is a middle-market private equity firm focused healthcare and industrials. The Vistria Group is a private investment firm.
“PANTHERx transforms lives by providing access solutions to people living with rare medical conditions,” said Jon Maschmeyer, senior partner at The Vistria Group. “Our investment was a collaborative effort to bring focus to an area that not only has been significantly underserved but also offers a wealth of opportunity to enhance the lives of patients.”